imipenem, anhydrous has been researched along with Pyrexia in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (11.29) | 18.7374 |
| 1990's | 32 (51.61) | 18.2507 |
| 2000's | 14 (22.58) | 29.6817 |
| 2010's | 9 (14.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferstl, PG; Grammatikos, G; Jozsa, K; Kempf, VA; Reinheimer, C; Waidmann, O; Zeuzem, S | 1 |
| Balm, M; Carter, J; Humble, M; Moniwa, A; Roohullah, A; Weinkove, R; Wood, C | 1 |
| Goldberg, D; Pacheco, JM | 1 |
| Gong, R; Huang, X; Li, C; Liu, J; Liu, Y; Xu, H | 1 |
| Buclin, T; Calandra, T; Lamoth, F; Marchetti, O; Pascual, A | 1 |
| Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
| Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
| Chochlakis, D; Ioannou, I; Psaroulaki, A; Tselentis, Y | 1 |
| Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Abbas, M; Decosterd, A; Emonet, S; Gétaz, L; Iten, A; Loutan, L; Merlani, P; Michel, Y; Schrenzel, J; Simon, F; Studer, R; Sudre, P | 1 |
| García-Cano Lizcano, J; Gómez-Ruiz, CJ; Jimeno-Ayllón, C; Martínez-Fernández, R; Morillas-Ariño, J; Pérez-García, JI; Pérez-Sola, Á; Serrano-Sánchez, L | 1 |
| Klastersky, JA | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Aoyagi, S; Hayashi, K; Horiuchi, H; Kawashima, Y; Kinoshita, H; Okuda, K; Shirouzu, K; Uchida, S; Yanase, A | 1 |
| Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C | 1 |
| Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
| Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
| Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC | 1 |
| Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T | 1 |
| Barros, KV; Bianchi, A; Kusano, E; Melaragno, R; Petrilli, AS; Ribeiro, RC; Silva, AA | 1 |
| Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
| Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Deaney, NB; Tate, H | 1 |
| Björkholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
| Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M | 1 |
| Arranz, R; Cámara, R; del Rey, MC; Fernández-Rañada, JM; Figuera, A; Hernández, L; Jiménez, ML; López-Lorenzo, JL; Peñarrubia, MJ; Tomás, JF | 1 |
| Hathorn, JW; Lyke, K | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Gaya, H | 1 |
| Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Klastersky, J | 1 |
| Garnache, F; Goffinet, P; Simon, M | 1 |
| Bartoni, K; Bruckner, DA; Schiller, GJ; Territo, MC; Winston, DJ | 1 |
| Abi-Said, D; Bodey, GP; Karl, CL; Raad, II; Rolston, KV | 1 |
| Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
| Aoun, M; Autier, P; Crokaert, F; Klastersky, J; Paesmans, M | 1 |
| Borja, J; Herreras, A | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Daenen, S; de Vries-Hospers, HG; Erjavec, Z; Halie, RM; Laseur, M | 1 |
| Anaissie, EJ; Gubbins, PO; McConnell, SA; Penzak, SR; Warmack, TS | 1 |
| Briggs, A; Feldman, C; Flitcroft, A; O'Grady, J; Richards, G; White, H | 1 |
| Frangié, C; Grenier, N; Lacut, JY; Morel, D; Pariente, JL; Potaux, L; Sassoust, G | 1 |
| Arranz, R; de La Cámara, R; Font, P; Leyra, F; María Fernández Rañada, J; Pajuelo, F; Rivero, N | 1 |
| Bareford, D; Bayston, KF; Bint, AJ; Cefai, C; Cohen, J; Leyland, MJ; Murray, SA; Newland, AC; Warren, R; White, DG | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV | 1 |
| Riikonen, P | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
| Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
| Huijgens, PC; Langenhuijsen, MM; Ossenkoppele, GJ; Simoons-Smit, AM; van Loenen, AC; van Pampus, EC; Weijers, TF; Wijermans, PW | 1 |
| Pizzo, PA; Rubin, M | 1 |
| Chan, TK; Chau, PY; Chiu, E; Lam, WK; Liang, R; Todd, D; Yung, R | 1 |
| Liu, CY; Wang, FD | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K | 1 |
| Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
| Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Leedom, JM; Yellin, AE | 1 |
| Bustamante, C; Devlin, A; Drusano, GL; Forrest, A; Plaisance, KI; Standiford, HC; Wade, JC | 1 |
| Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
5 review(s) available for imipenem, anhydrous and Pyrexia
| Article | Year |
|---|---|
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins | 2010 |
Use of imipenem as empirical treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia | 2003 |
A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients.
Topics: Cilastatin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia; Protease Inhibitors; Thienamycins; Treatment Outcome | 1996 |
Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Imipenem; Meropenem; Neutropenia; Thienamycins | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
34 trial(s) available for imipenem, anhydrous and Pyrexia
| Article | Year |
|---|---|
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2010 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome | 2004 |
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome | 2005 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 1994 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin | 1996 |
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Retreatment; Treatment Outcome | 1996 |
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins | 1996 |
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Thienamycins; Vancomycin | 1996 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Superinfection | 1998 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
Imipenem versus targeted therapy in cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoses; Neoplasms; Neutropenia; Thienamycins | 1998 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy.
Topics: Adult; Anti-Bacterial Agents; Body Temperature; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Neutropenia; Prospective Studies; Recurrence; Teicoplanin; Thienamycins; Treatment Outcome | 2000 |
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Anti-Infective Agents; Cilastatin; Drug Administration Schedule; Female; Fever; Fluoroquinolones; Follow-Up Studies; Humans; Imipenem; Male; Middle Aged; Molecular Structure; Pneumonia; Protease Inhibitors; Thienamycins | 2001 |
[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
Topics: Adolescent; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Fever; Gentamicins; Humans; Imipenem; Leukemia; Lymphoma; Middle Aged; Neutropenia; Piperacillin | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection | 1992 |
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin | 1991 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.
Topics: Antibiotics, Antineoplastic; Cilastatin; Drug Resistance, Microbial; Fever; Hematologic Diseases; Humans; Imipenem; Neutropenia; Time Factors | 1991 |
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Random Allocation; Remission Induction | 1989 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Imipenem/cilastatin therapy of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins | 1987 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
23 other study(ies) available for imipenem, anhydrous and Pyrexia
| Article | Year |
|---|---|
Severe infection with multidrug-resistant
Topics: Adult; Anti-Infective Agents; beta-Lactamases; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Fever; Humans; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections; Serogroup; Thailand; Travel; Ultrasonography | 2017 |
Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Drug Substitution; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
A curious cause of cavitations: Nocardia pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchoscopy; Clindamycin; Comorbidity; Fever; Hemoptysis; Humans; Imipenem; Immunocompromised Host; Lung Abscess; Male; Middle Aged; Neuroimaging; Nocardia Infections; Pneumonia, Bacterial; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Weight Loss | 2014 |
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candidiasis; Catheters; Diarrhea; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycoses; Penicillanic Acid; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Retrospective Studies; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vomiting | 2016 |
Imipenem underdosing as a cause of persistent neutropenic fever?
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia | 2009 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
Human anaplasmosis and Anaplasma ovis variant.
Topics: Adult; Anaplasma ovis; Anaplasmosis; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bites and Stings; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyprus; DNA, Bacterial; Doxycycline; Drug Combinations; Female; Fever; Genes, Bacterial; Humans; Imipenem; Phylogeny; Ticks | 2010 |
Fatal acute melioidosis in a tourist returning from Martinique Island, November 2010.
Topics: Abscess; Adult; Anti-Bacterial Agents; Burkholderia pseudomallei; Fatal Outcome; Fever; Geography; Humans; Imipenem; Male; Martinique; Mass Spectrometry; Melioidosis; Middle Aged; Sequence Analysis, DNA; Switzerland; Travel | 2011 |
Liver abscess mimicking colon cancer.
Topics: Aged; Anti-Bacterial Agents; Bacteroides Infections; Cholecystectomy; Citrobacter freundii; Colonic Neoplasms; Colonoscopy; Combined Modality Therapy; Diagnostic Errors; Drainage; Enterobacteriaceae Infections; Fever; Humans; Imipenem; Liver Abscess; Male; Streptococcal Infections; Surgical Wound Infection; Tomography, X-Ray Computed; Ultrasonography, Interventional; Viridans Streptococci | 2011 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
[A case of radiofrequency ablation therapy for recurrent hepatomas with tumor fever--efficacy of hepatic arterial infusion therapy with antibiotics and anticancer drugs].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Cefmetazole; Cilastatin; Cisplatin; Female; Fever; Hepatic Artery; Humans; Imipenem; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Recurrence, Local | 2004 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neutropenia | 1993 |
Carbapenems in febrile neutropenic patients.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
[Primary peritonitis caused by Streptococcus pneumoniae].
Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina | 1997 |
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
Topics: Adolescent; Adult; Aged; Cilastatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Protease Inhibitors; Retrospective Studies; Thienamycins; Treatment Outcome | 1998 |
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins | 1999 |
Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.
Topics: Adult; Aged; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Reactions; Drug Combinations; Drug Hypersensitivity; Fever; Humans; Imipenem; Incidence; Middle Aged; Neutropenia; Penicillins; Retrospective Studies | 2000 |
A rare infection in a renal transplant recipient.
Topics: Abscess; Anti-Bacterial Agents; Fever; Humans; Imipenem; Kidney Transplantation; Magnetic Resonance Angiography; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Postoperative Complications; Roxithromycin; Tomography, X-Ray Computed; Vancomycin | 2001 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones | 1990 |
Imipenem therapy for perforated and gangrenous appendicitis.
Topics: Adult; Aged; Appendectomy; Appendicitis; Ascitic Fluid; Cilastatin; Clindamycin; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Gangrene; Gentamicins; Humans; Imipenem; Intestinal Perforation; Length of Stay; Middle Aged; Rupture, Spontaneous; Thienamycins | 1986 |
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.
Topics: Adult; Aged; Agranulocytosis; Double-Blind Method; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Thienamycins | 1987 |